CoJourney Inc., a global innovator in manufacturing and development of cell and gene therapies, has completed a $30 million Series A financing and expansion of its U.S. organization and commercial manufacturing capabilities. CoJourney has developed high efficiency processes to support end-to-end custom development and manufacturing for genetic medicines, including plasmids, viral vectors, and mRNA. The company has built 130,000 sq.-ft. state-of-the-art cGMP manufacturing facilities that inclu...